Eligible patients and consumers organisations

Human medicines European public assessment report (EPAR): Docetaxel Kabi, docetaxel, Date of authorisation: 22/05/2012, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Date of authorisation: 19/09/2019, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Kalydeco, ivacaftor, Date of authorisation: 23/07/2012, Revision: 46, Status: Authorised

CHMP opinions on consultation procedures

13th Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 June 2025, 09:00 (CEST) to 30 June 2025, 13:15 (CEST)

Highlights - 13th Industry Standing Group (ISG) meeting

Human medicines European public assessment report (EPAR): Rezolsta, darunavir,cobicistat, Date of authorisation: 19/11/2014, Revision: 19, Status: Authorised

Scientific advice and protocol assistance adopted during the CHMP meeting 21- 24 July 2025

List of industry subject matter experts and list of planned calls for industry subject matter experts